Parkinson's disease is the second most common neurodegenerative disease after Alzheimer's, affecting approximately 1.2 million people in Europe. In addition to affecting the speech and movement centers, this progressive disease is associated with an increased incidence of mental health problems such as depression. Orbit Health's solution is designed to better assess patient response to treatment. This should enable physicians to optimize their treatment methods and improve the patient's quality of life.
“Parkinson’s is a complex disease, and each patient responds differently to treatment,”
explained Patty Lee, CEO and co-founder of Orbit Health.
“With our research, we want to make it easier to individualize therapies, thereby improving the lives of patients and their families and saving costs for the healthcare system.”
Orbit Health wins the Wild Card Innovation Program
Orbit Health has now secured €1.5 million in funding through EIT Health's 2020 Wild Card Innovation Program. Launched in 2017, the Wild Card program is aimed at talented innovators, teams, and individuals from across Europe, supporting them in realizing their ideas in the healthcare sector. In addition to financial support, it offers expert support and coaching for participants. Each year, the program announces two challenges for which new solutions are sought. These then select two winningStartups The second winning team in 2020 – MiMARK – is from Barcelona and is working on improving the accuracy and efficiency of uterine cancer diagnosis.
"Wild Card 2020 was a truly enriching experience that accelerated our understanding of how our solution fits into the market. We look forward to leveraging EIT Health's support, network, and influence to bring our solution into the hands of clinicians and patients,"
explains Patty Lee.
The Wild Card Innovation Program is taking place again this year. This time, we are looking for new ideas for the treatment of eye diseases and visual impairments, as well as for the relief of acute and chronic pain conditions. Individuals and teams of up to five members can still apply. Apply by March 16.
